Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126088531 | 12608853 | 1 | I | 20080514 | 20160730 | 20160730 | EXP | US-ASTRAZENECA-2008BM06943 | ASTRAZENECA | 0.00 | A | F | Y | 0.00000 | 20160730 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126088531 | 12608853 | 1 | PS | BYETTA | EXENATIDE | 1 | Unknown | 10.0UG UNKNOWN | U | 21773 | 10 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | ||||||
| 126088531 | 12608853 | 2 | SS | BYETTA | EXENATIDE | 1 | Unknown | 5.0UG UNKNOWN | U | 21773 | 5 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | ||||||
| 126088531 | 12608853 | 3 | SS | BYDUREON | EXENATIDE | 1 | Subcutaneous | 2.0MG UNKNOWN | U | U | 0 | 2 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126088531 | 12608853 | 3 | Type 2 diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126088531 | 12608853 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126088531 | 12608853 | Injection site bruising | |
| 126088531 | 12608853 | Pancreatitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |